Moderna Inc. (MRNA) - 5i Research

Moderna Inc. (MRNA $27.12)
- $27.12 Cap: $10.55B
- View MRNA Profile
- View Questions on MRNA

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $293.72)
- $293.72 P/E (TTM): 24.16X Cap: $158.12B
- View AMGN Profile
- View Questions on AMGN
PayPal Holdings Inc. (PYPL $69.90)
- $69.90 P/E (TTM): 14.5X Cap: $66.78B
- View PYPL Profile
- View Questions on PYPL
AbbVie Inc. (ABBV $210.60)
- $210.60 P/E (TTM): 89.53X Cap: $372.03B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $711.68)
- $711.68 P/E (TTM): 57.76X Cap: $673.57B
- View LLY Profile
- View Questions on LLY
Progressive Corporation (The) (PGR $249.21)
- $249.21 P/E (TTM): 14.03X Cap: $146.08B
- View PGR Profile
- View Questions on PGR
Prologis Inc. (PLD $112.28)
- $112.28 P/E (TTM): 29.29X Cap: $104.20B
- View PLD Profile
- View Questions on PLD
Moderna Inc. (MRNA $27.12)
- $27.12 Cap: $10.55B
- View MRNA Profile
- View Questions on MRNA
Enphase Energy Inc. (ENPH $38.18)
- $38.18 P/E (TTM): 26.81X Cap: $4.99B
- View ENPH Profile
- View Questions on ENPH
BioNTech SE (BNTX $110.88)
- $110.88 Cap: $26.60B
- View BNTX Profile
- View Questions on BNTX

Q: Given the potential for a market down-turn, do you see any of these as a good buy for a long-term investment?

Read Answer Asked by Camille on August 01, 2025

Abbott Laboratories (ABT $132.59)
- $132.59 P/E (TTM): 16.56X Cap: $230.76B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $711.68)
- $711.68 P/E (TTM): 57.76X Cap: $673.57B
- View LLY Profile
- View Questions on LLY
Pfizer Inc. (PFE $25.88)
- $25.88 P/E (TTM): 18.65X Cap: $147.14B
- View PFE Profile
- View Questions on PFE
Novo Nordisk A/S (NVO $56.98)
- $56.98 P/E (TTM): 15.74X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Moderna Inc. (MRNA $27.12)
- $27.12 Cap: $10.55B
- View MRNA Profile
- View Questions on MRNA

Q: Hello,

Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.

Thank you!

Read Answer Asked by Irek on February 14, 2025

Moderna Inc. (MRNA $27.12)
- $27.12 Cap: $10.55B
- View MRNA Profile
- View Questions on MRNA

Q: Hi, Could you please provide your opinion on MRNA current price/valuation/potential growth ? The stock is currently down -37% YTD. At this price, do you see a potential contrarian long term investment ? thank you

Read Answer Asked by Luc on October 08, 2024